TrialDiabetologia2009

Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial.

R R Holman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.